Live Oak Private Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,529
Closed -$354K 176
2024
Q1
$354K Sell
6,529
-302
-4% -$15.4K 0.06% 128
2023
Q4
$350K Buy
6,831
+778
+13% +$40.8K 0.07% 120
2023
Q3
$351K Sell
6,053
-200
-3% -$12.3K 0.07% 114
2023
Q2
$400K Hold
6,253
0.08% 113
2023
Q1
$433K Buy
6,253
+252
+4% +$17.8K 0.09% 113
2022
Q4
$432K Sell
6,001
-1,600
-21% -$121K 0.09% 118
2022
Q3
$540K Sell
7,601
-301
-4% -$21.8K 0.12% 110
2022
Q2
$608K Sell
7,902
-39,728
-83% -$3.03M 0.13% 114
2022
Q1
$3.48M Buy
47,630
+1,431
+3% +$96.1K 0.67% 57
2021
Q4
$2.88M Buy
46,199
+9,326
+25% +$547K 0.54% 57
2021
Q3
$2.18M Buy
36,873
+2,775
+8% +$183K 0.44% 61
2021
Q2
$2.28M Buy
34,098
+6,064
+22% +$395K 0.5% 57
2021
Q1
$1.77M Buy
28,034
+7,179
+34% +$447K 0.43% 62
2020
Q4
$1.29M Buy
20,855
+7,902
+61% +$486K 0.36% 62
2020
Q3
$781K Buy
12,953
+784
+6% +$47.2K 0.27% 73
2020
Q2
$716K Buy
12,169
+4,956
+69% +$296K 0.26% 73
2020
Q1
$402K Buy
7,213
+3,040
+73% +$186K 0.41% 44
2019
Q4
$268K Buy
+4,173
New +$239K 0.26% 64

Other funds holding BMY

Live Oak Private Wealth's BMY Position: Q2 2024 in Review

Live Oak Private Wealth sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 6,529 shares — an estimated $354K sold.

Live Oak Private Wealth first reported a position in BMY in Q4 2019 and held it in 18 quarters. The position peaked at $3.48M in Q1 2022. 2,147 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

  • Live Oak Private Wealth reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
  • Live Oak Private Wealth sold 6,529 Bristol-Myers Squibb shares in Q2 2024, an estimated $354K.
  • Live Oak Private Wealth first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 18 quarters.
  • Live Oak Private Wealth's Bristol-Myers Squibb position peaked at $3.48M in Q1 2022.
  • 2,147 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on Live Oak Private Wealth's 13F filing for Q2 2024, filed 17 Jul 2024.